Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa

NCT03638830 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

777

Enrollment

OTHER

Sponsor class

Conditions

Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
Pseudomonas Aeruginosa
Pseudomonas Infections
Urinary Tract Infections

Interventions

DRUG: Ftortiazinon (tablets 300 mg) 1/2 dose +placebo+ Maxipim
DRUG: Ftortiazinon (tablets 300 mg) full dose + Maxipim
OTHER: placebo+Maxipim

Sponsor

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Collaborators

[object Object]